Heart scarring scan may forecast future in dilated cardiomyopathy
NCT ID NCT02352129
First seen May 09, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This completed study looked at 262 people with dilated cardiomyopathy, a condition where the heart is enlarged and weak. Researchers used a special MRI technique (T1 mapping) to measure scarring (fibrosis) in the heart muscle. The goal was to see if the amount of scarring could predict serious events like death, need for a heart transplant, or hospitalization for heart problems. The study did not test any treatment but aimed to improve how doctors estimate a patient's outlook.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY, DILATED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict which patients with dilated cardiomyopathy are at higher risk of complications.
What could go wrong
This is an observational study, not a treatment trial. It may not change how patients are managed, and results may not apply to all types of cardiomyopathy.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.